Developer docs
API playgroundTry for free, no card

Search company profiles

Direct Diagnostics

Full company profile

uuid000eink

Namestring
Direct Diagnostics
Legal namestring
OralDNA Labs, A Service of Access Genetics LLC
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Direct Diagnostics operates OralDNA Labs, a CLIA-certified and CAP-accredited clinical laboratory marketed as a service of Access Genetics LLC, headquartered in Eden Prairie, Minnesota. The company provides salivary diagnostic testing services to dental and medical providers, with a primary customer base of general dentists, periodontists, and dental hygienists who order laboratory tests to support clinical decision-making in periodontal disease management, HPV-related oral cancer risk assessment, caries risk, and detection of Candida and HSV. All tests are run on a universal oral rinse collection kit — a 30-second swish-and-gargle sample collection protocol — analyzed via real-time quantitative PCR in the company's laboratory, with results returned to the ordering provider.

The product portfolio spans nine registered trademarks covering periodontal pathogens (MyPerioPath), combined periodontal-plus-genetic testing (Alert 2, which bundles MyPerioPath with MyPerioID IL-6), HPV oral cancer risk (OraRisk HPV), caries risk (OraRisk Caries), Candida detection (OraRisk Candida), herpes simplex virus detection (OraRisk HSV), and a comprehensive panel (Celsus One). The company has expanded technical capability through the acquisition of Sensible Diagnostics' patent-pending real-time qPCR platform, intended to enable point-of-care rapid PCR testing alongside its existing send-out laboratory model. No AI/ML capabilities are disclosed; the underlying technology is molecular diagnostics rather than computational.

Commercial activity is concentrated in the United States and executed through a sales-led, B2B model targeting dental practices. Providers order tests via the Access Genetics portal, and the company generates revenue on a per-test basis consistent with a clinical laboratory service model; pricing is not publicly disclosed. Distribution is augmented by a channel partnership with Pacific Dental Services (PDS), whose supported dental offices offer OralDNA testing, and by a Doctor Finder tool that funnels consumer interest toward participating providers. Marketing is built on clinical education assets — a weekly blog, monthly newsletter, case studies, protocol directory, and bibliography — plus active presence on LinkedIn, Facebook, Instagram, and YouTube.

Short descriptiontext

Direct Diagnostics operates OralDNA Labs, a CLIA-certified clinical laboratory that provides salivary diagnostic tests — including periodontal, HPV, caries, Candida, and HSV panels — to dental providers in the United States on a per-test billing basis.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Marcos, United States
HQ citystring
San Marcos
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
salivary diagnostic testing, clinical laboratory services, periodontal disease diagnostics, oral pathogen detection, molecular dental diagnostics
Industry3 codes
PRIMARYHLABACAL
Periodontal Diagnostics & Risk Assessment (Perio Charting/Microbial Testing)
Healthcare & Life Sciences/Dental Care Services/Periodontics (Gum & Implant Services)
SECONDARYHLABAHAF
Oral Cancer Screening
Healthcare & Life Sciences/Dental Care Services/Dental Hygiene & Preventive Services
SECONDARYHLABAHAE
Caries Risk Assessment & Preventive Planning
Healthcare & Life Sciences/Dental Care Services/Dental Hygiene & Preventive Services
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Laboratory Services / Dental Diagnostics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Salivary Diagnostic Testing Services
TypeOne Time License
Description

OralDNA Labs generates revenue by providing salivary diagnostic laboratory testing services to dental and medical providers. Providers order tests (e.g., MyPerioPath, OraRisk HPV, Alert 2) and send patient samples to the lab for analysis. Results are returned to the ordering provider for clinical decision-making. Revenue is derived from per-test billing, consistent with a clinical laboratory service model.

oraldna.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 8 records shown
1MyPerioPath®
Description

Early warning and detection tool for periodontal disease

oraldna.com
+7 more records
Core offering1 text field

Direct Diagnostics operates OralDNA Labs, a CLIA-certified clinical laboratory providing salivary diagnostic testing services to dental and medical providers. The company offers a portfolio of molecular diagnostic tests—including MyPerioPath, Alert 2, OraRisk HPV, OraRisk Caries, OraRisk Candida, OraRisk HSV, MyPerioID IL-6, and Celsus One—performed on patient saliva samples collected via a universal oral rinse kit. The service enables objective, laboratory-confirmed diagnostic data to support clinical decision-making in dentistry, including periodontal disease management, oral cancer risk assessment, caries risk evaluation, and detection of fungal and viral oral infections.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Pacific Dental Services concluded that OralDNA testing improves oral health outcomes in PDS-supported offices.
Product overview1 text field

OralDNA Labs (Direct Diagnostics) offers a platform of salivary diagnostic tests for oral health assessment. The portfolio centers on a universal oral rinse collection kit used across all tests, with individual diagnostic products including MyPerioPath® for periodontal disease detection, OraRisk HPV® for oral cancer risk screening, and additional tests for caries risk, fungal infections (Candida), and viral infections (HSV). The Alert 2™ product combines MyPerioPath® with MyPerioID® IL-6 genetic testing for comprehensive personalized periodontal care. The company recently expanded capabilities through acquisition of Sensible Diagnostics' real-time quantitative PCR testing platform.

Product and service9 records
1MyPerioPath®
CategoryPeriodontal Disease Diagnostics
Description

Salivary diagnostic test that analyzes oral bacteria to provide an early warning and detection tool for periodontal disease, helping dental healthcare providers understand the cause of gum disease and design targeted treatment plans.

2Alert 2™
CategoryPeriodontal Disease Diagnostics
Description

Combined salivary testing platform that integrates MyPerioPath® and MyPerioID® IL-6 to deliver targeted treatment and personalized care for patients with periodontal disease.

3OraRisk HPV®
CategoryOral Cancer Risk Assessment
Description

Salivary diagnostic test that determines increased risk for HPV-related oral cancers, enabling early detection and clinical intervention.

4MyPerioID IL-6
CategoryGenetic Marker Testing
Description

Genetic marker salivary test that identifies interleukin-6 (IL-6) genetic variations associated with inflammatory response in periodontal disease, supporting personalized care.

5OraRisk Caries
CategoryCaries Risk Assessment
Description

Salivary test that identifies bacteria associated with dental caries (cavities) risk to enable personalized preventive treatment.

6Celsus One
CategoryComprehensive Oral Health Panel
Description

Comprehensive salivary diagnostic panel providing multiple oral health biomarkers for complete patient assessment.

7OraRisk Candida
CategoryOral Infection Detection
Description

Salivary test that detects Candida species associated with oral fungal infections and related conditions.

8OraRisk HSV
CategoryOral Infection Detection
Description

Salivary diagnostic test for herpes simplex virus (HSV) detection to support diagnosis and management of oral herpes infections.

9Full Test Menu
CategoryClinical Laboratory Services
Description

Aggregated catalog of OralDNA Labs' complete salivary diagnostic test offerings, providing dental and medical providers a single menu of all available molecular diagnostic tests performed on the universal oral rinse collection kit.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Pacific Dental Services (PDS)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pacific Dental Services concluded that OralDNA testing improves oral health outcomes. PDS-supported dental offices now offer OralDNA salivary diagnostic testing to patients. This is a significant distribution channel partnership, with PDS operating a large network of supported dental practices.

oraldna.com
Strategic tierCoreTypeTechnology or Integration
Description

OralDNA Labs acquired Sensible Diagnostics' patent-pending real-time quantitative PCR testing platform. This acquisition brings advanced molecular diagnostic technology in-house, expanding OralDNA's technical capabilities and enabling point-of-care rapid PCR testing in addition to its existing laboratory-based salivary diagnostics.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Dentognostics develops and markets the PerioSafe/OralCheck chairside salivary aMMP-8 test for active periodontal disease — the most direct global competitor to OralDNA's MyPerioPath in objective salivary-based periodontal diagnostics.

TypeDirect peer
Description

Bako Diagnostics is a specialty diagnostic laboratory serving dental and podiatric providers with anatomic pathology and microbiology testing, directly overlapping OralDNA's dental-focused diagnostic lab model and target customer base.

TypeBroad incumbent
Description

Quest Diagnostics is a national clinical laboratory offering an extensive menu of diagnostic tests including HPV and infectious disease assays. It is comparable to OralDNA as a CLIA-certified reference lab, though it does not specialize in dental salivary diagnostics.

TypeBroad incumbent
Description

Labcorp is one of the largest clinical reference laboratories in the U.S., providing diagnostic testing services across specialties. It competes broadly in the clinical lab space and could expand into dental/periodontal diagnostics over time.

TypeBroad incumbent
Description

Sonic Healthcare is a global medical diagnostics provider operating reference laboratories across multiple specialties. It is comparable as a scaled, multi-specialty clinical lab that could plausibly enter the oral diagnostics category.

6Access Genetics (parent)
TypeOthers
Description

Access Genetics LLC is the parent operating company of OralDNA Labs and operates the ordering portal (portal.access-genetics.com). While not a peer in the commercial sense, it provides the corporate and billing infrastructure behind OralDNA.

7Interleukin Genetics (now Genetic Technologies)
TypeEmerging player
Description

Previously known for the PST genetic risk test for periodontal disease (a direct analog to OralDNA's MyPerioID IL-6). Comparable as a genetic-marker-based oral/periodontal risk assessment test, though now repositioned under Genetic Technologies with a broader focus.

TypeBroad incumbent
Description

Cepheid, a Danaher subsidiary, is a leader in real-time PCR molecular diagnostic systems (GeneXpert). Comparable to OralDNA's newly acquired Sensible Diagnostics qPCR platform as an established point-of-care molecular diagnostics platform that could expand into oral pathogen testing.

TypeBroad incumbent
Description

Hologic is a major molecular diagnostics company (e.g., Panther system, HPV testing). Comparable to OralDNA for its molecular diagnostic capabilities and leadership in HPV testing — the same pathogen family addressed by OralDNA's OraRisk HPV test.

10Dentsply Sirona
TypeBroad incumbent
Description

Dentsply Sirona is a global dental equipment, technology, and consumables leader with deep relationships across dental practices. Comparable to OralDNA as a dominant player in the dental industry that could bundle or vertically integrate diagnostics into its practice workflow offerings.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Direct Diagnostics

Clinical Laboratory Services / Dental Diagnosticsdirectdiagnostics.com

Direct Diagnostics operates OralDNA Labs, a CLIA-certified clinical laboratory that provides salivary diagnostic tests — including periodontal, HPV, caries, Candida, and HSV panels — to dental providers in the United States on a per-test billing basis.

What Direct Diagnostics does

Direct Diagnostics operates OralDNA Labs, a CLIA-certified and CAP-accredited clinical laboratory marketed as a service of Access Genetics LLC, headquartered in Eden Prairie, Minnesota. The company provides salivary diagnostic testing services to dental and medical providers, with a primary customer base of general dentists, periodontists, and dental hygienists who order laboratory tests to support clinical decision-making in periodontal disease management, HPV-related oral cancer risk assessment, caries risk, and detection of Candida and HSV. All tests are run on a universal oral rinse collection kit — a 30-second swish-and-gargle sample collection protocol — analyzed via real-time quantitative PCR in the company's laboratory, with results returned to the ordering provider.

The product portfolio spans nine registered trademarks covering periodontal pathogens (MyPerioPath), combined periodontal-plus-genetic testing (Alert 2, which bundles MyPerioPath with MyPerioID IL-6), HPV oral cancer risk (OraRisk HPV), caries risk (OraRisk Caries), Candida detection (OraRisk Candida), herpes simplex virus detection (OraRisk HSV), and a comprehensive panel (Celsus One). The company has expanded technical capability through the acquisition of Sensible Diagnostics' patent-pending real-time qPCR platform, intended to enable point-of-care rapid PCR testing alongside its existing send-out laboratory model. No AI/ML capabilities are disclosed; the underlying technology is molecular diagnostics rather than computational.

Commercial activity is concentrated in the United States and executed through a sales-led, B2B model targeting dental practices. Providers order tests via the Access Genetics portal, and the company generates revenue on a per-test basis consistent with a clinical laboratory service model; pricing is not publicly disclosed. Distribution is augmented by a channel partnership with Pacific Dental Services (PDS), whose supported dental offices offer OralDNA testing, and by a Doctor Finder tool that funnels consumer interest toward participating providers. Marketing is built on clinical education assets — a weekly blog, monthly newsletter, case studies, protocol directory, and bibliography — plus active presence on LinkedIn, Facebook, Instagram, and YouTube.

Direct Diagnostics firmographics

Firmographics
Name
Direct Diagnostics
Legal name
OralDNA Labs, A Service of Access Genetics LLC
Website
https://directdiagnostics.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Direct Diagnostics operates OralDNA Labs, a CLIA-certified clinical laboratory that provides salivary diagnostic tests — including periodontal, HPV, caries, Candida, and HSV panels — to dental providers in the United States on a per-test billing basis.
Ownership category
akta.pro rank

Direct Diagnostics industry classification

Industry
Product category
Clinical Laboratory Services / Dental Diagnostics
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLABACAL
Periodontal Diagnostics & Risk Assessment (Perio Charting/Microbial Testing)
Healthcare & Life Sciences/Dental Care Services/Periodontics (Gum & Implant Services)
SECONDARYHLABAHAF
Oral Cancer Screening
Healthcare & Life Sciences/Dental Care Services/Dental Hygiene & Preventive Services
SECONDARYHLABAHAE
Caries Risk Assessment & Preventive Planning
Healthcare & Life Sciences/Dental Care Services/Dental Hygiene & Preventive Services

Keywords

  • Salivary diagnostic testing
  • Clinical laboratory services
  • Periodontal disease diagnostics
  • Oral pathogen detection
  • Molecular dental diagnostics

Where Direct Diagnostics is headquartered

Location

Headquarters

HQ city
San Marcos
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Direct Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Salivary Diagnostic Testing Services: OralDNA Labs generates revenue by providing salivary diagnostic laboratory testing services to dental and medical providers. Providers order tests (e.g., MyPerioPath, OraRisk HPV, Alert 2) and send patient samples to the lab for analysis. Results are returned to the ordering provider for clinical decision-making. Revenue is derived from per-test billing, consistent with a clinical laboratory service model.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Direct Diagnostics product offering

Product offering

Core offering

Direct Diagnostics operates OralDNA Labs, a CLIA-certified clinical laboratory providing salivary diagnostic testing services to dental and medical providers. The company offers a portfolio of molecular diagnostic tests—including MyPerioPath, Alert 2, OraRisk HPV, OraRisk Caries, OraRisk Candida, OraRisk HSV, MyPerioID IL-6, and Celsus One—performed on patient saliva samples collected via a universal oral rinse kit. The service enables objective, laboratory-confirmed diagnostic data to support clinical decision-making in dentistry, including periodontal disease management, oral cancer risk assessment, caries risk evaluation, and detection of fungal and viral oral infections.

Product overview

OralDNA Labs (Direct Diagnostics) offers a platform of salivary diagnostic tests for oral health assessment. The portfolio centers on a universal oral rinse collection kit used across all tests, with individual diagnostic products including MyPerioPath® for periodontal disease detection, OraRisk HPV® for oral cancer risk screening, and additional tests for caries risk, fungal infections (Candida), and viral infections (HSV). The Alert 2™ product combines MyPerioPath® with MyPerioID® IL-6 genetic testing for comprehensive personalized periodontal care. The company recently expanded capabilities through acquisition of Sensible Diagnostics' real-time quantitative PCR testing platform.

Differentiator

Problem solved

Functional benefit

Brands

  • MyPerioPath®: Early warning and detection tool for periodontal disease
  • Alert 2™
  • OraRisk HPV®
  • OraRisk Caries
  • OraRisk Candida
  • OraRisk HSV
  • Celsus One
  • MyPerioID IL-6

Products and services

  • MyPerioPath® Salivary diagnostic test that analyzes oral bacteria to provide an early warning and detection tool for periodontal disease, helping dental healthcare providers understand the cause of gum disease and design targeted treatment plans.
  • Alert 2™ Combined salivary testing platform that integrates MyPerioPath® and MyPerioID® IL-6 to deliver targeted treatment and personalized care for patients with periodontal disease.
  • OraRisk HPV® Salivary diagnostic test that determines increased risk for HPV-related oral cancers, enabling early detection and clinical intervention.
  • MyPerioID IL-6 Genetic marker salivary test that identifies interleukin-6 (IL-6) genetic variations associated with inflammatory response in periodontal disease, supporting personalized care.
  • OraRisk Caries Salivary test that identifies bacteria associated with dental caries (cavities) risk to enable personalized preventive treatment.
  • Celsus One Comprehensive salivary diagnostic panel providing multiple oral health biomarkers for complete patient assessment.
  • OraRisk Candida Salivary test that detects Candida species associated with oral fungal infections and related conditions.
  • OraRisk HSV Salivary diagnostic test for herpes simplex virus (HSV) detection to support diagnosis and management of oral herpes infections.
  • Full Test Menu Aggregated catalog of OralDNA Labs' complete salivary diagnostic test offerings, providing dental and medical providers a single menu of all available molecular diagnostic tests performed on the universal oral rinse collection kit.

Quantifiable outcome

  • Pacific Dental Services concluded that OralDNA testing improves oral health outcomes in PDS-supported offices.

Companies that use Direct Diagnostics

Customer profile

Named customers8 records

Segments1 record

Ideal customer profiles2 records

Direct Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Direct Diagnostics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Pacific Dental Services (PDS)coreChannel Partner/ Reseller/ DistributorPacific Dental Services concluded that OralDNA testing improves oral health outcomes. PDS-supported dental offices now offer OralDNA salivary diagnostic testing to patients. This is a significant distribution channel partnership, with PDS operating a large network of supported dental practices.
  • Sensible DiagnosticscoreTechnology or IntegrationOralDNA Labs acquired Sensible Diagnostics' patent-pending real-time quantitative PCR testing platform. This acquisition brings advanced molecular diagnostic technology in-house, expanding OralDNA's technical capabilities and enabling point-of-care rapid PCR testing in addition to its existing laboratory-based salivary diagnostics.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct Diagnostics competitors and assessment

Company assessment

Direct peers

  • Dentognostics: Dentognostics develops and markets the PerioSafe/OralCheck chairside salivary aMMP-8 test for active periodontal disease — the most direct global competitor to OralDNA's MyPerioPath in objective salivary-based periodontal diagnostics.
  • Bako Diagnostics: Bako Diagnostics is a specialty diagnostic laboratory serving dental and podiatric providers with anatomic pathology and microbiology testing, directly overlapping OralDNA's dental-focused diagnostic lab model and target customer base.

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is a national clinical laboratory offering an extensive menu of diagnostic tests including HPV and infectious disease assays. It is comparable to OralDNA as a CLIA-certified reference lab, though it does not specialize in dental salivary diagnostics.
  • Laboratory Corporation of America (Labcorp): Labcorp is one of the largest clinical reference laboratories in the U.S., providing diagnostic testing services across specialties. It competes broadly in the clinical lab space and could expand into dental/periodontal diagnostics over time.
  • Sonic Healthcare: Sonic Healthcare is a global medical diagnostics provider operating reference laboratories across multiple specialties. It is comparable as a scaled, multi-specialty clinical lab that could plausibly enter the oral diagnostics category.
  • Cepheid (Danaher): Cepheid, a Danaher subsidiary, is a leader in real-time PCR molecular diagnostic systems (GeneXpert). Comparable to OralDNA's newly acquired Sensible Diagnostics qPCR platform as an established point-of-care molecular diagnostics platform that could expand into oral pathogen testing.
  • Hologic: Hologic is a major molecular diagnostics company (e.g., Panther system, HPV testing). Comparable to OralDNA for its molecular diagnostic capabilities and leadership in HPV testing — the same pathogen family addressed by OralDNA's OraRisk HPV test.
  • Dentsply Sirona: Dentsply Sirona is a global dental equipment, technology, and consumables leader with deep relationships across dental practices. Comparable to OralDNA as a dominant player in the dental industry that could bundle or vertically integrate diagnostics into its practice workflow offerings.

Others

  • Access Genetics (parent): Access Genetics LLC is the parent operating company of OralDNA Labs and operates the ordering portal (portal.access-genetics.com). While not a peer in the commercial sense, it provides the corporate and billing infrastructure behind OralDNA.

Emerging players

  • Interleukin Genetics (now Genetic Technologies): Previously known for the PST genetic risk test for periodontal disease (a direct analog to OralDNA's MyPerioID IL-6). Comparable as a genetic-marker-based oral/periodontal risk assessment test, though now repositioned under Genetic Technologies with a broader focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Direct Diagnostics social profiles

Digital presence

Direct Diagnostics compliance and trust

Trust signal

Compliance2 records

Direct Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Direct Diagnostics leadership team

Management profile

Number of profiles

Profiles1 record

Direct Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Direct Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Direct Diagnostics

What does Direct Diagnostics do?

Direct Diagnostics operates OralDNA Labs, a CLIA-certified clinical laboratory providing salivary diagnostic testing services to dental and medical providers. The company offers a portfolio of molecular diagnostic tests—including MyPerioPath, Alert 2, OraRisk HPV, OraRisk Caries, OraRisk Candida, OraRisk HSV, MyPerioID IL-6, and Celsus One—performed on patient saliva samples collected via a universal oral rinse kit. The service enables objective, laboratory-confirmed diagnostic data to support clinical decision-making in dentistry, including periodontal disease management, oral cancer risk assessment, caries risk evaluation, and detection of fungal and viral oral infections.

Is Direct Diagnostics a public or private company?

Direct Diagnostics is a private company. It is classified as management employee owned and is currently operating.

When was Direct Diagnostics founded?

Direct Diagnostics was founded in 2015. It employs 1 to 10 people.

Where is Direct Diagnostics based?

Direct Diagnostics is headquartered in San Marcos, United States, in the North America region.

How does Direct Diagnostics make money?

One revenue line is on record: salivary Diagnostic Testing Services.

Who are Direct Diagnostics's main competitors?

Direct peers on record are Dentognostics and Bako Diagnostics. Broad incumbents are Quest Diagnostics, Laboratory Corporation of America (Labcorp), Sonic Healthcare, Cepheid (Danaher), Hologic and Dentsply Sirona. Access Genetics (parent) is listed as an others. Interleukin Genetics (now Genetic Technologies) is listed as an emerging player.

Does Direct Diagnostics have an API?

No public API is recorded for Direct Diagnostics.

What industry is Direct Diagnostics in?

Direct Diagnostics's product category is Clinical Laboratory Services / Dental Diagnostics. Its primary akta.pro industry code is HLABACAL, Periodontal Diagnostics & Risk Assessment (Perio Charting/Microbial Testing), with a secondary code of HLABAHAF, Oral Cancer Screening. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals